Bridgewater Associates »

Bridgebio Pharma shares owned by Bridgewater Associates

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Bridgewater Associates from 13F filings

Historical chart of Bridgewater Associates investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Bridgewater Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Bridgewater Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $19M 260k 74.26
2025-12-31 $3.3M 43k 76.49

More positions owned by Bridgewater Associates

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Micron Technology (MU)
Microsoft Corporation (MSFT)
Ge Vernova (GEV)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)
Newmont Mining Corporation (NEM)
Oracle Corporation (ORCL)
Ishares Msci Sth Kor Etf (EWY)

View all positions for Bridgewater Associates

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Viking Global Investors
Farallon Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Jane Street
Geode Capital Management
Invesco
Susquehanna International

View all funds holding Bridgebio Pharma